cMedia Release Zurich, March 21, 2022 Xlife Sciences and curasan form joint venture company to research biosurgical treatment therapies . | March 21, 2022
11.02.2022 - DGAP-Ad-hoc: Xlife Sciences AG / Key word(s): IPO Xlife Sciences AG: Xlife Sciences shares begin trading on SIX Swiss Exchange 11-Feb-2022 / 07:13 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No . Seite 1
Xlife Sciences AG / Key word(s): IPOXlife Sciences AG: Xlife Sciences' shares begin trading on SIX Swiss Exchange11-Feb-2022 / 07:13 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsi.
<p><span>Today, Xlife Sciences listed its shares on Sparks - making it the very first listing on the new and regulated SME segment of SIX Swiss Exchange.</span></p>